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Background: The use of radio frequency identification (RFID) systems in healthcare
is increasing, and concerns for electromagnetic compatibility (EMC) pose one of the
biggest obstacles for widespread adoption. Numerous studies have demonstrated
that RFID systems can interfere with medical devices; however, the majority of past
studies relied on time-consuming and burdensome test schemes based on ad hoc
test methods applied to individual RFID systems.
Methods: This paper presents the results of using an RFID simulator that allows for
faster evaluation of RFID-medical device EMC against a library of RFID test signals at
various field strengths.
Results: The results of these tests demonstrate the feasibility and adequacy of
simulator testing and can be used to support its incorporation into applicable
consensus standards.
Conclusions: This work can aid the medical device community in better assessing
the risks associated with medical device exposure to RFID.
Keywords: Electromagnetic compatibility, Electromagnetic interference, EMC, EMI,
Radio-frequency identification, RFID, Medical device, Test methods, SimulatorBackground
The use of radio frequency identification (RFID) systems in healthcare is increasing
and concerns for electromagnetic compatibility (EMC) pose one of the biggest obsta-
cles for widespread adoption. Numerous studies have demonstrated that RFID systems
can interfere with medical devices [1-8] and previous ad hoc testing by FDA [8]
demonstrated the need for a standardized test method, as it is impractical and time
consuming to test for EMC between a medical device and individual RFID systems.
RFID signal output, field strength, frequency, and separation distance are all factors
that can contribute to the likelihood of electromagnetic interference (EMI). IEC
60601-1-2:2007 (the EMC test standard for non-implantable medical devices) has
no immunity requirements at 125 kHz nor a radiated immunity requirement at
13.56 MHz. Additionally, the radiated immunity requirements at 915 MHz and
2.4 GHz do not represent the potential field strengths allowed by the FCC. As such,© 2014 Seidman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated.
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shown by Seidman et al. [1,8].
Because there are currently no standards that specify tests for medical device immun-
ity to RFID emissions, medical device manufacturers typically demonstrate immunity
through ad hoc testing, which has been shown to be both time consuming and labor
intensive [8]. Previously it has been shown that by utilizing an RFID signal simulator it
might be possible to test for a variety of RFID signals and field strengths, without the
need for actual RFID systems [9]. Simulators described in detail in [10] are intended to
provide an alternative means of testing for RFID emissions that is both faster and more
reproducible. This type of testing would also provide medical device manufacturers
with a better understanding of the RFID systems that could affect their devices, and
this information can be used to improve device design.
The research described in this paper was performed to determine (1) simulator test-
ing feasibility and adequacy and (2) if a broad range of input signals is necessary or if
the test library can be simplified. Evaluation of the feasibility and adequacy of this
simulator and the test library is important to support their incorporation into applic-
able medical device EMC standards.
Methods
As discussed in Seidman et al. [10], separate simulators were developed to cover four
distinct RFID frequency bands: Low frequency (LF): 125 kHz; High frequency (HF):
13.56 MHz; Ultra high frequency (UHF): 915 MHz; and 2.4 GHz. At 125 kHz and
13.56 MHz, Helmholtz Coils were designed to produce the radiated magnetic field
strength (see Figure 1). At 915 MHz and 2.4 GHz, the exposure setup was similar to
that described by IEC 61000-4-3, with an adjusted input signal and field strength ac-
cording to the RFID test library (see Figure 2). The input signals are intended to emu-
late the applicable RFID standards with the various RFID reader settings adjusted to
create a signal with the maximum and minimum occupied bandwidth. A summary of
these signals, named the RFID Test Library is presented in Table 1.
An infusion pump and three different patient monitors were tested against the RFID
Test Library. To begin, each medical device was placed on a non-conductive surface
and configured for normal operation. Normal operation for the infusion pump was spe-
cified as delivering saline at its minimum flow rate of 100 ml/hr. Normal operation forFigure 1 Magnetic field exposure systems. Photos of 125 kHz (a) and 13.56 MHz (b) exposure systems.
Figure 2 Electric field exposure systems. Photos of 915 MHz (a) and 2.4 GHz (b) exposure systems.
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lator (Dynatech Nevada Inc, Model 214A) set to output a normal sinus rhythm at 80
beats per minute to the acquisition module of the monitor. The patient simulator was
placed in a shielded box to exclude any EMI that might have occurred with the simula-
tor itself. We began testing the patient monitor with the acquisition module exposed as
it would be configured in clinical use. However, the acquisition modules were extremely
susceptible to EMI, and as the objective of this testing was to determine the feasibility
of the test protocol and appropriateness of the RFID Test Library; we decided to gather
additional data with the acquisition module shielded from exposure.
After normal operation of the device was confirmed, each device was exposed to an
RFID test signal at maximum field strength from the RFID test library. Each device was
exposed to four orientations for each RFID test signal: front, back, left, and right. Depend-
ing on the implementation and geometry of the device it could be helpful to expose the
top and bottom orientation as well. Magnetic field testing in a Helmholtz coil is somewhat
more efficient than electric field radiated testing in a chamber because the parallel (or per-
pendicular) orientation exposes both the front and back (or left and right) sides simultan-
eously. All medical devices were visually and audibly monitored during exposure with a
surveillance video camera. Any observable changes in device operation were recorded for
all tests and classified based on the severity of the interference. If EMI was observed at
the maximum field strength, we performed an additional test to discover the threshold at
which EMI began. During threshold testing, the field strength was increased in incre-
ments of approximately 10% from 1 A/m to 12 A/m, until the first instance of EMI was
observed. After EMI occurred, the field strength was lowered and the device was verified
to return to normal operation. Next the field was returned to the level that caused the
EMI and the threshold was verified. The dwell time for each exposure was 15 seconds.
Results
Observed EMI ranged from device mode changes to screen errors. Device mode changes
and screen errors that made display information unreadable were considered probably
clinically significant (Class I). Small display changes where the display information was
still identifiable were considered probably not clinically significant (Class II).
We observed EMI (Class I or II) during 24% (75 of 312) of our maximum field
strength experiments with 76% (57 of 75) being classified as Class I. EMI was observed
during 25% (6 of 24) of maximum field strength tests at 125 kHz; during 100% (48 of
Table 1 The RFID Test library
Frequency Occupied
bandwidth
Standard Program settings Maximum field
strength
125 kHz (LF) Max ISO 14223 Type A Modulation Depth 100% 65 A/m
ETU: 3 usec
Min ISO 14223 Type A Modulation Depth 90% 65 A/m
ETU: 12 u sec
13.56 MHz (HF) Max ISO 14443 Type A Pulse Width: 3 usec 12 A/m
Transition Edge: 1 nsec
Min ISO 14443 Type A Pulse Width: 2 usec 12 A/m
Transition Edge: 2.98 usec
Max ISO 14443 Type B Modulation Depth: 25% 12 A/m
Transition Edge: 0.001 usec
SOF Low: 11 etu
SOF High: 2.5 etu
EOF Low: 10.5 etu
Min ISO 14443 Type B Modulation Depth: 15% 12 A/m
Transition Edge: 1.17 usec
SOF Low: 10 etu
SOF High: 2 etu
EOF Low: 10 etu
Max ISO 15693 Modulation Depth: 100% 12 A/m
Pulse Width: 9.44 usec
Transition Edge: 1 nsec
Min ISO 15693 Modulation Depth: 10% 12 A/m
Pulse Width: 7.5 usec
Transition Edge: 800 nsec
915 MHz (UHF) Max ISO 18000-6C Modulation: DSB-ASK 54 V/m
Tari: 6.25 us
Pulse Width: 3.281 usec
Modulation Depth: 100%
Max ISO 18000-6C Modulation: DSB-ASK 54 V/m
Tari: 25 us
Pulse Width: 0.265 Tari
Modulation Depth: 80%
Min ISO 18000-6C Modulation: PR-ASK 54 V/m
Tari: 6.25 usec
Pulse Width: 1.656 usec
Min ISO 18000-6C Modulation: PR-ASK 54 V/m
Tari: 25 usec
Pulse Width: 0.525 Tari
2.45 GHz Max ISO 18000–4 Mode 1 Modulation Depth: 100% 54 V/m
Transition Edge: 1 nsec
Tari: 25 usec
Min ISO 18000–4 Mode 2 Modulation Depth: 90% 54 V/m
Transition Edge: 400 nsec
Tari: 33 usec
The RFID Test Library is a collection of test signals and field strengths that are representative for most commercially
available RFID readers (RMS).
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field strength tests at 915 MHz; and during 3% (2 of 80) of maximum field strength
tests at 2.4 GHz. The numbers above are inclusive of all tests, including experiments
that were originally performed with the patient acquisition module exposed; for the re-
mainder of this section we will ignore those experiments to minimize variables and
concentrate purely on the appropriateness of the RFID Test Library.
During maximum field strength exposure to 13.56 MHz test signals, we observed EMI
in 100% (48 of 48) of the tests. Class I EMI was observed for all three patient monitors
and Class II EMI was observed for the infusion pump. No EMI was observed during ex-
posure to 125 kHz (0 of 16), 915 MHz (0 of 128) and 2.4 GHz (0 of 64) RFID test signals.
At the maximum field strength it was not possible to determine any effect of different
RFID test signals within each frequency band because every 13.56 MHz RFID test signal
caused EMI. Thus for these cases where EMI was observed, we also found the field
strength threshold where EMI began. We could then use these threshold values to com-
pare the effects of different RFID tests signals within each frequency band. There were six
13.56 MHz RFID test signals (three different standards each tested at both maximum and
minimum bandwidth). Results for these tests are presented in Table 2 below:Table 2 Threshold EMI values at 13.56 MHz for parallel and perpendicular orientations
for all devices
Device # RFID Standard
protocol
Threshold H-Field strength (A/m RMS)
Parallel Perpendicular
1 ISO 14443 Type A Max 4.5 4.5
ISO 14443 Type A Min 4.5 6.5
ISO 14443 Type B Max 4.5 4
ISO 14443 Type B Min 4 4
ISO 15693 Max 4 3.5
ISO 15693 Min 4.5 3.5
2 ISO 14443 Type A Max 10.5 12
ISO 14443 Type A Min 10.5 12
ISO 14443 Type B Max 10.5 9.5
ISO 14443 Type B Min 10.5 12
ISO 15693 Max 10.5 11.5
ISO 15693 Min 10.5 11.5
3 ISO 14443 Type A Max 12 12
ISO 14443 Type A Min 12 12
ISO 14443 Type B Max 12 12
ISO 14443 Type B Min 12 12
ISO 15693 Max 12 12
ISO 15693 Min 12 12
4 ISO 14443 Type A Max 12 12
ISO 14443 Type A Min 12 12
ISO 14443 Type B Max 12 12
ISO 14443 Type B Min 12 12
ISO 15693 Max 12 12
ISO 15693 Min 12 12
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This study aimed to determine (1) simulator testing feasibility and adequacy and (2) if
all proposed input signals are necessary or if the test library can be simplified. Test
feasibility and adequacy was verified by demonstrating that the simulator can be used
to determine medical device-RFID EMC. Little variation was seen comparing the differ-
ent RFID protocols and the maximum versus minimum bandwidth. The average differ-
ence comparing threshold field strengths between different standards was only 0.25 A/m
and the average difference comparing the maximum versus the minimum bandwidth was
only 0.23 A/m. Additionally, identical EMI was observed for all patient monitors tested
across the six protocols. While only four medical devices were tested, this data collected
tends to suggest that, while signal modulation has an effect, the greater influence is the
overall field strength. This would support minimizing the RFID Test Library to one signal
per frequency. However, threshold testing was only performed at 13.56 MHz and more
testing with more medical devices is needed to verify simplification of the RFID Test Li-
brary. Since little variation was seen between the different RFID protocols future tests
should consider whether the specified modulation defined in IEC 60601-1-2:2007 is ad-
equate with the appropriate higher test levels.
Varying EMC performance was seen between devices. Device 1 exhibited EMI at an
average field strength of 4.3 A/m, while all of the other medical devices exhibited EMI
at an average field strength between 11 A/m and 12 A/m. While our results confirm
the potential of RFID EMI to medical devices, we do not recommend using this data
for clinical decisions. First, there were only four devices tested in this study and they
do not represent a broad enough selection of medical device types or manufacturers.
Secondly, the devices were overexposed for a portion of the testing performed. A max-
imum test level of 12 A/m was chosen at 13.56 MHz for all three different standards.
However, while ISO 18000–3 Mode 1 specifies a maximum field strength of 12 A/m,
ISO/IEC 14443 and ISO/IEC 15693 specify 7.5 A/m and 5 A/m, respectively (over the
manufacturer’s specified volume). Similarly the 54 V/m test level at 2.4 GHz is a theor-
etical maximum at 20 cm. In our experience the field values from 2.4 GHz readers are
less than 2 V/m at this distance. Finally, during threshold testing the patient monitor
acquisition modules were shielded from interference. Many medical devices sense vital
signs from the body and a modulated RF signal can be misinterpreted as one coming
from a patient by that unit if it is exposed. In clinical use, the acquisition module would
be exposed, resulting in EMI at lower field strengths than those reported here.
A side by side comparison of our simulator data to actual RFID readers would be
helpful to demonstrate that our test accurately portrays exposure from actual RFID
readers. However, there are some practical reasons why these tests were not performed.
Primarily this was not performed because testing to a maximum field in a volume or
over an area as described in our test method is generally understood to be a more
rigorous exposure than testing with an actual RFID reader, where the maximum field
will be localized and decrease with distance. This means that passing our test is more
difficult than passing a test with actual RFID readers. Additionally, we were not able to
reproduce all of the field levels with actual RFID readers, as explained in the prior para-
graph. We did do some testing using actual RFID readers as the signal input, but with
our same exposure system. As expected, this data was consistent with that found from
using the signals from the RFID Test Library.
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Medical devices have been shown to be susceptible to EMI from RFID and current
medical device EMC standards do not adequately test electromagnetic immunity of
medical devices to RFID systems. This study has demonstrated the feasibility and ad-
equacy of using simulators and the RFID Test Library to test medical devices for EMC
with RFID. Using simulators, we have shown that testing can be performed much faster
than in ad hoc testing with individual RFID systems. The results from our tests demon-
strate that, while signal modulation has an effect on medical devices, the greater influ-
ence is the overall field strength. Tests are also more repeatable than in ad hoc testing
because the hardware configuration remains unchanged from test to test and results
are not affected by small changes in antenna orientation.
Medical device manufacturers could use these simulators to test if their devices are
susceptible to RFID emissions. This test can be used to assist the medical device com-
munity to identify and resolve potential EMI that could be caused by RFID systems
and provide assurance to hospitals that RFID technology will not adversely affect their
medical devices. It has also been shown to be suitable for incorporation into applicable
consensus standards.
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